ADIM
WGS icon

Alpha DNA Investment Management’s GeneDx Holdings WGS Stock Holding History

Alpha DNA Investment Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,238
Closed -$403K – 181
2024
Q4 		$403K Sell
5,238
-4,998
-49% -$349K 0.15% 173
2024
Q3 		$434K Sell
10,236
-3,639
-26% -$123K 0.16% 157
2024
Q2 		$363K Buy
+13,875
New +$263K 0.14% 180

Other funds holding WGS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Alpha DNA Investment Management's WGS Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of GeneDx Holdings (WGS) in Q1 2025, closing a stake of 5,238 shares — an estimated $403K sold.

Alpha DNA Investment Management first reported a position in WGS in Q2 2024 and held it in 3 quarters. The position peaked at $434K in Q3 2024. 225 funds tracked by Wall St. Rank hold WGS as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining GeneDx Holdings position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 5,238 GeneDx Holdings shares in Q1 2025, an estimated $403K.
  • Alpha DNA Investment Management first reported a position in GeneDx Holdings in Q2 2024 and held it in 3 quarters.
  • Alpha DNA Investment Management's GeneDx Holdings position peaked at $434K in Q3 2024.
  • 225 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.